NASDAQ:MOTS - Motus GI Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.01 +0.06 (+1.52 %)
(As of 03/21/2019 04:00 PM ET)
Previous Close$3.95
Today's Range$3.82 - $4.09
52-Week Range$2.34 - $10.66
Volume47,700 shs
Average Volume52,520 shs
Market Capitalization$62.92 million
P/E Ratio-3.13
Dividend YieldN/A
BetaN/A
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MOTS
CUSIPN/A
Phone786-459-1831

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10,000.00

Profitability

Net Income$-13,200,000.00

Miscellaneous

Employees39
Market Cap$62.92 million
Next Earnings Date3/27/2019 (Estimated)
OptionableNot Optionable

Motus GI (NASDAQ:MOTS) Frequently Asked Questions

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

How were Motus GI's earnings last quarter?

Motus GI Holdings Inc (NASDAQ:MOTS) posted its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by $0.06. View Motus GI's Earnings History.

When is Motus GI's next earnings date?

Motus GI is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Motus GI.

What price target have analysts set for MOTS?

5 brokers have issued 1-year price targets for Motus GI's stock. Their forecasts range from $8.00 to $14.50. On average, they anticipate Motus GI's share price to reach $10.50 in the next twelve months. This suggests a possible upside of 161.8% from the stock's current price. View Analyst Price Targets for Motus GI.

What is the consensus analysts' recommendation for Motus GI?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motus GI.

Has Motus GI been receiving favorable news coverage?

Media headlines about MOTS stock have trended neutral on Thursday, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Motus GI earned a media sentiment score of 0.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the stock's share price in the near term.

Who are some of Motus GI's key competitors?

What other stocks do shareholders of Motus GI own?

Who are Motus GI's key executives?

Motus GI's management team includes the folowing people:
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 57)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 48)
  • Mr. Timothy P. Moran, CEO & Director

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Who are Motus GI's major shareholders?

Motus GI's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Perceptive Advisors LLC (20.46%), Nantahala Capital Management LLC (3.19%), RTW Investments LP (2.93%), Hilltop Holdings Inc. (0.70%), Eaton Vance Management (0.45%) and Maven Securities LTD (0.38%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Institutional Ownership Trends for Motus GI.

Which institutional investors are selling Motus GI stock?

MOTS stock was sold by a variety of institutional investors in the last quarter, including Hilltop Holdings Inc.. View Insider Buying and Selling for Motus GI.

Which institutional investors are buying Motus GI stock?

MOTS stock was acquired by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, RTW Investments LP, Perceptive Advisors LLC, Maven Securities LTD, Eaton Vance Management and IPG Investment Advisors LLC. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Insider Buying and Selling for Motus GI.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $4.01.

How big of a company is Motus GI?

Motus GI has a market capitalization of $62.92 million and generates $10,000.00 in revenue each year. The company earns $-13,200,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis. Motus GI employs 39 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is http://www.motusgi.com.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 786-459-1831 or via email at [email protected]


MarketBeat Community Rating for Motus GI (NASDAQ MOTS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  189
MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/21/2019 by MarketBeat.com Staff

Featured Article: Balanced Fund

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel